Related Experiment Video
Updated: Sep 21, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Gene Expression Meta-Analysis of Potential Shared and Unique Pathways between Autoimmune Diseases under Anti-TNFα
Charalabos Antonatos1, Mariza Panoutsopoulou1, Georgios K Georgakilas1,2
1Laboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.
Abstract:
While anti-TNFα has been established as an effective therapeutic approach for several autoimmune diseases, results from clinical trials have uncovered heterogeneous patients' response to therapy. Here, we conducted a meta-analysis on the publicly available gene expression cDNA microarray datasets that examine the differential expression observed in response to anti-TNFα therapy with psoriasis (PsO), inflammatory bowel disease (IBD) and rheumatoid arthritis (RA). Five disease-specific meta-analyses and a single combined random-effects meta-analysis were performed through the restricted maximum likelihood method. Gene Ontology and Reactome Pathways enrichment analyses were conducted, while interactions between differentially expressed genes (DEGs) were determined with the STRING database. Four IBD, three PsO and two RA datasets were identified and included in our analyses through our search criteria. Disease-specific meta-analyses detected distinct pro-inflammatory down-regulated DEGs for each disease, while pathway analyses identified common inflammatory patterns involved in the pathogenesis of each disease. Combined meta-analyses further revealed DEGs that participate in anti-inflammatory pathways, namely IL-10 signaling. Our analyses provide the framework for a transcriptomic approach in response to anti-TNFα therapy in the above diseases. Elucidation of the complex interactions involved in such multifactorial phenotypes could identify key molecular targets implicated in the pathogenesis of IBD, PsO and RA.
Insights
Anti-tumor necrosis factor (TNFα) therapy shows varied responses in autoimmune diseases like psoriasis (PsO), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA). This meta-analysis reveals distinct gene expression patterns and common anti-inflammatory pathways, including IL-10 signaling, in response to anti-TNFα treatment.
Area of Science:
- Immunology
- Genomics
- Computational Biology
Background:
- Anti-tumor necrosis factor alpha (anti-TNFα) therapy is a cornerstone treatment for autoimmune diseases.
- Patient responses to anti-TNFα therapy are highly variable, necessitating a deeper understanding of underlying mechanisms.
- Psoriasis (PsO), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA) are key autoimmune conditions where anti-TNFα efficacy is observed but patient heterogeneity exists.
Purpose of the Study:
- To conduct a meta-analysis of gene expression data from patients with PsO, IBD, and RA treated with anti-TNFα therapy.
- To identify differentially expressed genes (DEGs) and enriched pathways associated with treatment response across these diseases.
- To explore common and disease-specific molecular mechanisms influenced by anti-TNFα therapy.
Main Methods:
- Meta-analysis of publicly available gene expression cDNA microarray datasets for IBD, PsO, and RA.
- Restricted maximum likelihood method for five disease-specific and one combined random-effects meta-analyses.
- Gene Ontology and Reactome Pathway enrichment analyses, and STRING database for gene interaction analysis.
Main Results:
- Identified distinct pro-inflammatory DEGs that were down-regulated in each disease-specific meta-analysis.
- Pathway analyses revealed common inflammatory patterns contributing to the pathogenesis of IBD, PsO, and RA.
- Combined meta-analyses highlighted DEGs involved in anti-inflammatory pathways, particularly Interleukin-10 (IL-10) signaling.
Conclusions:
- This study provides a transcriptomic framework for understanding anti-TNFα therapy response in IBD, PsO, and RA.
- The findings suggest that IL-10 signaling plays a crucial role in the anti-inflammatory effects of anti-TNFα therapy.
- Further elucidation of these complex molecular interactions could identify novel therapeutic targets for these autoimmune diseases.
Related Concept Videos
The JAK-STAT Signaling Pathway
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway

